The Education and Lifestyle as Elements of Type 2 Diabetes Therapy
DOI:
https://doi.org/10.12775/QS.2025.39.58454Keywords
Diabetes, Epidemiology, complications, lifestyle, educationAbstract
Introduction
Type 2 diabetes is the most common disorder of carbohydrate metabolism, characterized by high blood glucose levels. This disease has become one of the major global health issues. Treatment of type 2 diabetes involves both pharmacotherapy and lifestyle changes, with patient education playing a key role in the effectiveness of therapy. The goal of treatment is to prevent complications and improve the quality of life for patients.
Aim of the Study
The aim of this paper is to discuss the role of education and lifestyle in the therapy of type 2 diabetes.
Materials and Methods
This work was written based on a review of the current literature available through PubMed and other databases The following keywords were used for the literature review: “diabetes”, “epidemiology”, “complications”, “lifestyle”, and “education”. This allowed for an analysis of the pathogenesis, diagnosis, education, and lifestyle as elements of treatment, as well as complications associated with diabetes.
Conclusions
Type 2 diabetes is one of the most prevalent chronic diseases worldwide, with the incidence and prevalence continuously increasing. Early diagnosis and proper patient education are crucial in treatment, as they enable effective lifestyle modification, better disease management, and a reduction in the risk of complications. Diabetes education increases patient engagement in treatment, leading to better metabolic control and improved quality of life. In the future, further promotion of education will be important, as it will help in the earlier diagnosis of diabetes and reduce the number of its complications.
References
1. Scheen AJ. Pathophysiology of type 2 diabetes. Acta Clin Belg. 2003 Nov;58(6):335–41.
2. WHO. World Health Organization. (2016). Physical activity strategy for the WHO European Region 2016–2025. WHO Regional Office for Europe.
3. Chung WK, Erion K, Florez JC, Hattersley AT, Hivert MF, Lee CG, et al. Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020 Sep;63(9):1671–93.
4. De Franco E, Flanagan SE, Houghton JAL, Lango Allen H, Mackay DJG, Temple IK, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015 Sep 5;386(9997):957–63.
5. Genuth S, Alberti KGMM, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003 Nov;26(11):3160–7.
6. Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, et al. Long-term sustainability of diabetes prevention approaches: A systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017 Dec 1;177(12):1808–17.
7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393–403.
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12;321(7258):405–12.
9. Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019 Aug;42(8):1593–603.
10. Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med. 2014 Aug;174(8):1227–34.
11. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020 Jan 7;41(2):255–323.
12. Czech A, Tatoń J. Definition, Epidemiometry, and Indicators of the Development of Diabetes Epidemic, Diabetes, ed. ed.CA, Tatoń J, Elamed W, editors. 2009;17–27.
13. Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis - a systematic review. Ann Intensive Care. 2011 Jul 6;1(1):23.
14. Dhatariya KK, Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med. 2022 Jun;39(6):e14788.
15. Dhatariya KK, Vellanki P. Treatment of diabetic ketoacidosis (DKA)/hyperglycemic hyperosmolar state (HHS): Novel advances in the management of hyperglycemic crises (UK versus USA). Curr Diab Rep. 2017 May;17(5):33.
16. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009 Jul;32(7):1335–43.
17. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab. 2013 May;98(5):1845–59.
18. Abraham SB, Arunachalam S, Zhong A, Agrawal P, Cohen O, McMahon CM. Improved real-world glycemic control with continuous glucose monitoring system predictive alerts. J Diabetes Sci Technol. 2021 Jan;15(1):91–7.
19. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008 Apr 1;26(2):77–82.
20. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2001 Oct;32(10):2426–32.
21. Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis: A meta-analysis. Arch Ophthalmol. 2011 Apr;129(4):435–44.
22. de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes Management in Chronic Kidney Disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022 Dec 1;45(12):3075–90.
23. Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):31–8.
24. Senneville É, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Aragón-Sánchez J, et al. Diagnosis of infection in the foot of patients with diabetes: A systematic review. Diabetes Metab Res Rev. 2024 Mar;40(3):e3723.
25. Otto-Buczkowska E, Marciniak-Brzezińska M. Specyficzne problemy edukacji diabetologicznej. Forum Medycyny Rodzinnej. 2016;10(4):212–8.
26. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes. 2004 Jul 1;22(3):123–7.
27. American Diabetes Association. Standards of care in diabetes-2023 abridged for primary care providers. Clin Diabetes. 2022 Dec 12;41(1):4–31.
28. Odgers-Jewell K, Ball LE, Kelly JT, Isenring EA, Reidlinger DP, Thomas R. Effectiveness of group-based self-management education for individuals with Type 2 diabetes: a systematic review with meta-analyses and meta-regression. Diabet Med. 2017 Aug;34(8):1027–39.
29. Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015 Jun;38(6):1008–15.
30. Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015 Sep;115(9):1447–63.
31. American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008 Jan;31 Suppl 1(Supplement_1):S61–78.
32. Medrela-Kuder E. Proper diet in type 2 diabetes as a means of patients’ rehabilitation. Rocz Panstw Zakl Hig. 2011;62(2):219–23.
33. Kołpa M, Grochowska A, Kubik B, Stradomska K. Lifestyle, metabolic compensation in patients with type 2 diabetes mellitus and the risk of chronic disease complications. Clinical Diabetology. 2018;7(3):151–8.
34. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003 Jun;26(6):1902–12.
35. Czarnecki D, Skalski DW, Kowalski D, Vynogradskyi B, Grygus I. AKTYWNOŚĆ FIZYCZNA SENIORÓW WARUNKIEM ZDROWIA I DOBREJ JAKOŚCI ŻYCIA. Реабілітаційні та фізкультурно-рекреаційні аспекти розвитку людини (Rehabilitation & recreation). 2022 Oct 12;(12):105–12.
36. Journal of physical education and sport [Internet]. Vol. 21. Physical Education and Sport Faculty; 2021. Available from: http://dx.doi.org/10.7752/jpes.2021.02093
37. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010 Dec;33(12):e147–67.
38. Jelleyman C, Yates T, O’Donovan G, Gray LJ, King JA, Khunti K, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis: The effects of HIIT on metabolic health. Obes Rev. 2015 Nov;16(11):942–61.
39. Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, et al. Exercise/physical activity in individuals with type 2 diabetes: A consensus statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022 Feb 1;54(2):353–68.
40. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci. 2008;1129(1):287–304.
41. Lee DY, Jung I, Park SY, Yu JH, Seo JA, Kim KJ, et al. Sleep duration and the risk of type 2 diabetes: A community-based cohort study with a 16-year follow-up. Endocrinol Metab (Seoul). 2023 Feb;38(1):146–55.
42. Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med Rev. 2017 Feb;31:91–101.
43. Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, Idewaki Y, et al. Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care. 2013 Mar;36(3):611–7.
44. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003 Mar;45(5):405–13.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zuzanna Adriana Przybyłek-Stępień, Jan Szustak, Ryszard Bartosiński, Michał Wijata, Anna Wijata, Justyna Dutkiewicz, Wiktoria Mączyńska, Maria Kąpa, Bartosz Szepietowski, Jakub Kaźmierczak, Ewelina Rycerz, Piotr Pasek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 164
Number of citations: 0
